These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24041469)

  • 21. Efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine on placental parasitemia in pregnant women in midwestern Nigeria.
    Aziken ME; Akubuo KK; Gharoro EP
    Int J Gynaecol Obstet; 2011 Jan; 112(1):30-3. PubMed ID: 20947080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
    Maiga AS; Diakite M; Diawara A; Sango HA; Coulibaly CO
    Mali Med; 2010; 25(3):41-8. PubMed ID: 21441083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reaching the unreached: effectiveness and satisfaction with community-directed distribution of sulfadoxine-pyrimethamine for preventing malaria in pregnancy in rural South-East, Nigeria.
    Okedo-Alex IN; Akamike IC; Alo CN; Agu AP; Nzeh CB; Ndukwe CD; Okoro OO; Abateneh DD; Uneke CJ
    Malar J; 2020 Nov; 19(1):394. PubMed ID: 33160375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decomposition of socioeconomic inequalities in the uptake of intermittent preventive treatment of malaria in pregnancy in Nigeria: evidence from Demographic Health Survey.
    Okoli CI; Hajizadeh M; Rahman MM; Khanam R
    Malar J; 2021 Jul; 20(1):300. PubMed ID: 34217299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
    Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
    BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of four or more doses of sulfadoxine pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Zambia: findings from the 2018 malaria in pregnancy survey.
    Sinyange D; Mukumbuta N; Mutale LS; Mumbole H; Hamainza B; Sialubanje C
    BMJ Open; 2023 May; 13(5):e073287. PubMed ID: 37236665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of intermittent preventive treatment of malaria among women attending antenatal clinics in primary health care centers in Ogbomoso, Oyo State, Nigeria.
    Adewole AO; Fawole O; Ajayi I; Yusuf B; Oladimeji A; Waziri E; Nguku P; Ajumobi O
    Pan Afr Med J; 2019; 33():101. PubMed ID: 31489079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.
    Ndeserua R; Juma A; Mosha D; Chilongola J
    Afr Health Sci; 2015 Sep; 15(3):810-8. PubMed ID: 26957969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
    Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali.
    Diarra SS; Konaté D; Diawara SI; Tall M; Diakité M; Doumbia S
    J Parasitol; 2019 Apr; 105(2):299-302. PubMed ID: 30969162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge, and attitude of service user of intermittent preventive treatment of malaria in pregnancy using sulfadoxine pyrimethamine in the Volta Region of Ghana.
    Asem L; Abdulia AG; Assuming PO; Abeka-Nkrumah G
    PLoS One; 2024; 19(9):e0309340. PubMed ID: 39240950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors associated with the failure of Intermittent Preventive Treatment for malaria among pregnant women in Yaounde].
    Essiben F; Foumane P; de Nguefack MA; Eko FE; Njotang PN; Enow RM; Mboudou ET
    Pan Afr Med J; 2016; 23():152. PubMed ID: 27303570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
    Umeh UA; Obi SN; Onah HE; Ugwu EO; Ajah LO; Umeh CR; Okafor II
    Trop Doct; 2012 Jul; 42(3):133-5. PubMed ID: 22399105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
    Mbonye AK; Schultz Hansen K; Bygbjerg IC; Magnussen P
    Public Health; 2008 May; 122(5):516-25. PubMed ID: 18358506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
    Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
    Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The provider's checklist to improve pregnant women coverage by intermittent preventive malaria treatment in Mali: a pilot implementation study.
    Doumbia I; Seydou F; Diakalia K; Bennis I
    Malar J; 2021 Oct; 20(1):402. PubMed ID: 34656113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women.
    Tukur IU; Thacher TD; Sagay AS; Madaki JK
    Am J Trop Med Hyg; 2007 Jun; 76(6):1019-23. PubMed ID: 17556604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of intermittent preventive treatment for malaria in pregnancy among women in selected communities of Ebonyi State, Nigeria.
    Akpa CO; Akinyemi JO; Umeokonkwo CD; Bamgboye EA; Dahiru T; Adebowale AS; Ajayi IO
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):457. PubMed ID: 31791271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.